Pharmaceutical Development

Organized by AIChE’s Society for Biological Engineering (SBE), the 8th International Conference on Accelerating Biopharmaceutical Development will be held September 6-8, 2023 in The Royal Sonesta Boston, Cambridge, MA.

Hear from AccBio Conference keynote speaker Raymond Deshaies about the future of biopharmaceutical development.

This award is presented to individuals or teams exhibiting exceptional leadership in industries served by chemical engineers.

Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.

Hear Ryan's perspective on what advances he thinks chemical engineering has ahead of it.

Humans have roughly 40 trillion bacterial cells in their bodies; up to 1,000 species of bacteria live in the human gut alone.

Microorganisms have long been used to help humans carry out various processes such as brewing and the production of antibiotics, but these processes remain very complex, with bioreactors seen as “b

A new experimental broad-spectrum antiviral drug could be used to combat the type of virus that causes the common cold and pneumonia, as well as more lethal viruses such as SARS and MERS.

A new report released by the European Centre for Disease Prevention and control (ECDC) emphasizes that antimicrobial resistance remains one of the greatest public health threats today.

New imagine of a key protein's signaling mechanism provides insights for better pharmaceuticals.

A new technique labels gene segments to help understand how the virus enters a cell and establishes co-infections.

In its first year, BioTM is already topping the charts, with top ratings for viewing, sharing, and discussion of articles.

The failure rate for new drugs and therapies under development exceeds 95%.

Using nanostraws, scientists can now sample cell contents without disrupting a cell's natural processes.

Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.

Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer

The 2016 D.I.C.

A startup in southern California is designing microbes that extend DNA beyond the natural A, T, G, and C components to include X and Y.

AIChE and the Society for Biological Engineering (SBE) have launched with publishing partner Wiley the new open-access journal Bioengineering & Translational Medicine, whose

The U.S. government announced this week that it is putting aside $55 million to create a public database with health information on about one million volunteers.

AccBio 2015 is a four-day conference focusing on scientific, technical, business and regulatory advances in the field of biopharmaceutical development.